These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1681963

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Suppression of natural killer cell differentiation by activated T lymphocytes in long-term cultures of mouse bone marrow.
    Delfino DV, Lepri E, Ayroldi E, Migliorati G, Boggs SS, Riccardi C.
    Exp Hematol; 1998 Jan; 26(1):2-9. PubMed ID: 9430508
    [Abstract] [Full Text] [Related]

  • 43. Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells.
    Lu L, Herberman RB, DeLeo AB.
    Nat Immun; 1994 Jan; 13(6):315-30. PubMed ID: 7894202
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes.
    Hackett J, Bosma GC, Bosma MJ, Bennett M, Kumar V.
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3427-31. PubMed ID: 2871552
    [Abstract] [Full Text] [Related]

  • 46. Inhibition of murine natural killer cell differentiation by dehydroepiandrosterone.
    Risdon G, Moore TA, Kumar V, Bennett M.
    Blood; 1991 Nov 01; 78(9):2387-91. PubMed ID: 1834253
    [Abstract] [Full Text] [Related]

  • 47. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
    Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V.
    J Immunol; 1986 Dec 15; 137(12):3742-7. PubMed ID: 3782794
    [Abstract] [Full Text] [Related]

  • 48. Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma.
    Lu J, Patrene KD, Appasamy PM, Herberman RB, Boggs SS.
    Exp Hematol; 1999 Jun 15; 27(6):1046-56. PubMed ID: 10378894
    [Abstract] [Full Text] [Related]

  • 49. Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes.
    Barlozzari T, Herberman RB, Reynolds CW.
    Proc Natl Acad Sci U S A; 1987 Nov 15; 84(21):7691-5. PubMed ID: 3478719
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E, Savary CA.
    Nat Immun; 1993 Nov 15; 12(4-5):209-17. PubMed ID: 8257827
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Hypothalamic control of the generation of mature natural killer lymphocytes in bone marrow and spleen of the mouse.
    Belluardo N, Mudó G, Cardile V, Migliorati G, Riccardi C, Cella S, Bindoni M.
    Nat Immun Cell Growth Regul; 1990 Nov 15; 9(1):26-35. PubMed ID: 2184351
    [Abstract] [Full Text] [Related]

  • 55. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB, Itoh K, Balch CM.
    J Immunol; 1987 Feb 15; 138(4):1068-73. PubMed ID: 3100627
    [Abstract] [Full Text] [Related]

  • 56. The development of NK cell activity in thymectomized bone marrow chimaeras.
    Sihvola M, Hurme M.
    Immunology; 1984 Sep 15; 53(1):17-22. PubMed ID: 6147307
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Phenotypic characterization of murine lymphokine-activated killer cells.
    Owen-Schaub LB, Abraham SR, Hemstreet GP.
    Cell Immunol; 1986 Dec 15; 103(2):272-86. PubMed ID: 2879640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.